1![en77 Original Article Improved Handling of Synonymous SNOMED CT Concepts used in HL7 Version 3 by the Example of the Von Willebrand Disease en77 Original Article Improved Handling of Synonymous SNOMED CT Concepts used in HL7 Version 3 by the Example of the Von Willebrand Disease](https://www.pdfsearch.io/img/6bde0b8a6fe0c3fd8294763676f81545.jpg) | Add to Reading ListSource URL: www.ejbi.orgLanguage: English - Date: 2017-06-28 11:48:09
|
---|
2![Supplementary Materials Supplementary Figure 1. Ternary von Willebrand Factor A1-glycoprotein Ibalpha-botrocetin complex (PDB code: 1U0N) as an example of a non-interacting protein pair. Red – Von Willebrand factor (1 Supplementary Materials Supplementary Figure 1. Ternary von Willebrand Factor A1-glycoprotein Ibalpha-botrocetin complex (PDB code: 1U0N) as an example of a non-interacting protein pair. Red – Von Willebrand factor (1](https://www.pdfsearch.io/img/44d2781ede62c36f9d7f1061e2577a7d.jpg) | Add to Reading ListSource URL: mips.helmholtz-muenchen.deLanguage: English - Date: 2013-10-04 12:05:00
|
---|
3![Article pH-Dependent Interactions in Dimers Govern the Mechanics and Structure of von Willebrand Factor Jochen P. Mu¨ller,1,* Achim Lo¨f,1 Salome´ Mielke,1 Tobias Obser,2 Linda K. Bruetzel,1 Willem Vanderlinden,1,3 J Article pH-Dependent Interactions in Dimers Govern the Mechanics and Structure of von Willebrand Factor Jochen P. Mu¨ller,1,* Achim Lo¨f,1 Salome´ Mielke,1 Tobias Obser,2 Linda K. Bruetzel,1 Willem Vanderlinden,1,3 J](https://www.pdfsearch.io/img/77ec4f50b72467cef65e3c32349013e2.jpg) | Add to Reading ListSource URL: www.biophysik.physik.uni-muenchen.deLanguage: English - Date: 2016-07-28 04:23:33
|
---|
4![News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites](https://www.pdfsearch.io/img/396d2f711c1ba36c7e8772bdd39b2346.jpg) | Add to Reading ListSource URL: www.cslbehring.atLanguage: English - Date: 2013-11-18 05:52:30
|
---|
5![News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites](https://www.pdfsearch.io/img/35bd0bec8c3b019145b7592aad0f5759.jpg) | Add to Reading ListSource URL: www.cslbehring.atLanguage: English - Date: 2013-11-18 05:52:29
|
---|
6![IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic IP Internship project 7: Detailed characterisation of the molecular interaction between complement factor H (FH) and von Willebrand factor (VWF) Description Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic](https://www.pdfsearch.io/img/002516d8100cab18910ea4f2c5db322b.jpg) | Add to Reading ListSource URL: www.sanquin.nlLanguage: English - Date: 2015-11-10 06:17:54
|
---|
7![CrossMark_Color_flat+click CrossMark_Color_flat+click](https://www.pdfsearch.io/img/b88177baa90d0f245371362529fa940b.jpg) | Add to Reading ListSource URL: www.biophysik.physik.uni-muenchen.deLanguage: English - Date: 2016-01-25 04:04:04
|
---|
8![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR](https://www.pdfsearch.io/img/a95341231cc895b7fd92fa6fb90b6c11.jpg) | Add to Reading ListSource URL: labeling.cslbehring.comLanguage: English - Date: 2016-05-26 14:29:43
|
---|
9![Major Therapeutic Products Marketed by CSL Behring Bleeding Disorders Coagulation therapies are used to treat bleeding disorders such as hemophilia, Von Willebrand Disease and more. Major Therapeutic Products Marketed by CSL Behring Bleeding Disorders Coagulation therapies are used to treat bleeding disorders such as hemophilia, Von Willebrand Disease and more. ](https://www.pdfsearch.io/img/3510bd8e3583661cb2009bb9c6cd79cf.jpg) | Add to Reading ListSource URL: www.cslbehring.comLanguage: English - Date: 2016-03-15 19:08:23
|
---|
10![UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A • UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •](https://www.pdfsearch.io/img/cc71a8e8ea7b8b663c6726f71a6f0d53.jpg) | Add to Reading ListSource URL: www.nektar.comLanguage: English - Date: 2015-07-30 13:12:07
|
---|